Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

NICHD Funds Major Effort to Determine Extent And Causes Of Stillbirth

20.11.2003

One of the National Institutes of Health has begun a concerted effort to determine the extent and causes of stillbirth- the death of a fetus at 20 or more weeks of pregnancy. Each year, more than 26,000 American women are reported to experience a stillbirth.

To date, it has been difficult to collect information on stillbirths because the criteria for reporting them vary from state to state, and the issuance of fetal death certificates is not required.

The National Institute of Child Health and Human Development (NICHD) awarded nearly $3 million to fund a national research effort to study stillbirth in the United States. The award will fund the Stillbirth Research Collaborative Network, consisting of five research centers around the country and an independent data center to collect and analyze statistics on stillbirth. The research and statistical centers will collaborate with the NICHD to design studies to determine the causes of stillbirth. The five-year effort will also seek to develop standardized research guidelines for reporting and investigating stillbirths.

The number of reported deaths from stillbirth is equal to that of all infant deaths combined. Some causes of stillbirth are known, such as diabetes or high blood pressure affecting the mother. However, the cause of more than half of all stillbirths is unknown.

"Stillbirth is a problem that affects families everywhere, but little is known about why it happens," said Duane Alexander, M.D., Director of the NICHD. "A better understanding of stillbirth may lead to ways to prevent these deaths."

The five sites in the Stillbirth Research Collaborative Network will work with local hospitals to track stillbirths for the study. A variety of specialists, from obstetricians to grief counselors, will participate in the research initiative to support the mothers and their families, and to develop guidelines for studying and reporting stillbirths. "Parents who suffer the loss of a fetus are often desperate for information about the cause," said Catherine Spong, M.D., Chief of NICHD’s Pregnancy and Perinatology Branch. "We hope this research will give us better information about stillbirth and its causes."

The Stillbirth Research Collaborative Network grew out of the March 2001 NICHD workshop, Setting a Research Agenda for Stillbirth, which brought experts from the U.S. and several other countries together to address the serious, but under-studied, problem of stillbirth.

The Stillbirth Research Collaborative Network includes the following clinical investigators and research sites: Dr. Marshall Carpenter, Women and Infants Hospital of Rhode Island in Providence; Dr. Donald Dudley, University of Texas Health Sciences Center in San Antonio; Dr. George Saade, University of Texas Medical Branch at Galveston; Dr. Robert Silver, University of Utah in Salt Lake City; Dr. Barbara Stoll, Emory University in Atlanta, and Dr. Corette Parker, at the statistical center at Research Triangle Institute in Raleigh, North Carolina.

The NICHD is part of the National Institutes of Health (NIH), the biomedical research arm of the federal government. NIH is an agency of the U.S. Department of Health and Human Services. The NICHD sponsors research on development, before and after birth; maternal, child, and family health; reproductive biology and population issues; and medical rehabilitation. NICHD publications, as well as information about the Institute, are available from the NICHD Web site, http://www.nichd.nih.gov, or from the NICHD Information Resource Center, 1-800-370-2943; e-mail NICHDInformationResourceCenter@mail.nih.gov

Robert Bock | NICHD
Further information:
http://www.nichd.nih.gov

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>